Jiangsu Pharma’s Quetiapine Extended-Release Tablets: High Quality Treatment for Mood/Mental Disorders

Quetiapine extended-release tablets are pharmaceutical grade tablets designed to treat certain mood/mental conditions. These include schizophrenia, bipolar disorder, sudden episodes of mania or depression associated with bipolar disorder. The tablets release Quetiapine into your system over a longer period allowing for once-daily dosing. These tablets come in dosages of 75mg, 150mg and 300mg, letting your healthcare provider choose the right dose for you.

• Manufactured in the renowned industrial hub of Jiangsu, this product guarantees high-quality standards and stringent quality control procedures.
• Fits exceptionally well within the pharmacological class of atypical antipsychotics, thanks to its balanced blend of efficacy and tolerability.
• Primarily acts on the brain's neurotransmitters, namely dopamine receptors and serotonin receptors, bringing a holistic approach to mental health management.
• Benefits from an exceptional logP value indicating its suitable lipid solubility and a reasonable absorption level, enhancing its bioavailability.
• Optimal molecular weight further ensures a steady absorption and distribution in the body.
• Does not cause carcinogenicity or teratogenicity which assures safety for long-term use.
• Strict adherence to global safety standards, including GHS classification, and accompanied by complete hazard and precautionary statements.

Targeted at the Central/South America, Asia, Middle East, and Africa markets, Quetiapine extended-release tablets come with convenient payment terms of T/T (telegraphic transfer). Please note that sample provision is not available for this product.